Inhaled or systemic corticosteroids and the risk of hospitalization for hip fracture among elderly women

American Journal of Medicine

Volumn 114, Issue 2, 2003, Pages 142-145

  Lau, Elaine ^a   Mamdani, Muhammad ^a,c,e   Tu, Karen ^b,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e Institute for Clinical and Evaluative Sciences   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETAMETHASONE; BUDESONIDE; CORTICOSTEROID; CORTISONE; DEXAMETHASONE; ESTROGEN; FLUDROCORTISONE; FLUNISOLIDE; FLUTICASONE; HYDROCORTISONE; LANSOPRAZOLE; MEPREDNISONE; OMEPRAZOLE; PANTOPRAZOLE; PREDNISONE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TRIAMCINOLONE;

AGED; AGING; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG EXPOSURE; DRUG FORMULATION; ESTROGEN THERAPY; FEMALE; HIP FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK;

EID: 0037313689     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01475-4     Document Type: Article

References (29)

1. Adinoff A.D., Hollister J.R. Steroid induced fractures and bone loss in patients with asthma. N Engl J Med. 309:1983;265-268.
2. Luengo M., Picado C. Vertebral fractures in steroid dependent asthma and involutional osteoporosis a comparative study. Thorax. 46:1991;803-806.
3. Van Staa T.P., Leufkens H.G.M., Abenhaim L., et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 15:2000;993-1000.
4. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 54:1995;49-52.
5. Ryrfeldt A., Anderson P., Edsbacker S., et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis. 63:1982;. 86-85.
6. Harding S.M. The human pharmacology of fluticasone propionate. Respir Med. 84:1990;25-29.
7. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 94:1993;646-650.
8. Melton L.J. III, Chrischilles E.A., Lane A.W., et al. How many women have osteoporosis? J Bone Miner Res. 9:1992;1005-1010.
9. Wisniewski A.F., Lewis S.A., Green D.J., et al. Cross-section investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. Thorax. 52:1997;853-860.
10. Wong C.A., Walsh L.J., Smith C.J.P., et al. Inhaled corticosteroid use and bone mineral density in patients with asthma. Lancet. 355:2000;1399-1403.
11. Hanania N.A., Chapman K.R., Sturtridge W.C., et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 96:1995;571-579.
12. Toogood J.H., Baskerville J.C., Markov A.E., et al. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol. 96:1995;157-166.
13. McEnvoy C.E., Kristine E.E., Bender E. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 157:1998;704-708.
14. Cummings S.R., Nevitt M.C., Browner W.S., et al. Risk factors of hip fracture in white women. N Engl J Med. 332:1995;767-773.
15. Van Staa T.P., Leufkens H.G.M., Cooper C. Use of inhaled corticosteroids and the risk of fractures. J Bone Min Res. 16:2001;581-588.
16. Matthews K., Kuller L., Wing L., et al. Prior use of estrogen replacement therapy, are users healthier than non-users? Am J Epidemiol. 143:1996;971-978.
17. Grodstein F., Stampler M.J., Falkeborn M., et al. Post-menopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology. 5:1999;476-480.
18. Larcos G. What factors influence general practitioners' commencement of hormone replacement in perimenopausal women? Br J Clin Pract. 50:1996;6-8.
19. Rozenburg S., Lefever A., Kroll M., et al. Prescription attitudes among gynecologists towards two particular risk factors for osteoporosis the patient's age and her bone mineral density. Maturitas. 32:1999;19-24.
20. Hanania N.A., Chapman K.R., Sturtridge W.C., et al. Dose related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 96:1995;571-579.
21. Liu B., Anderson G., Mittman N., et al. Use of selective-serotonin reuptake inhibitors or tricyclic antidepressants and risks of hip fractures in elderly people. Lancet. 351:1998;1303-1307.
22. Tinetti M.E., Speechley M. Prevention of falls in the elderly. N Engl J Med. 320:1989;1055-1059.
23. Rubenstein L.Z., Josephson K.R., Robbins A.S. Falls in nursing home. Ann Intern Med. 121:1994;442-451.
24. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45:1992;613-619.
25. Praet J.P., Peretz A., Rozenburg S., et al. Risk of osteoporosis in men with chronic bronchitis. Osteoporos Int. 2:1992;257-261.
26. Riancho JA, Gonzalez Macias J, Del Arco C, et al. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. Thorax. 987;42:962-966.
27. Reid D.M., Nicholl J.J., Smith M.A., et al. Corticosteroids and bone mass in asthma comparisons with rheumatoid arthritis and polymyalgia rheumatica. BMJ. 293:1986;1463-1466.
28. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 54:1995;49-52.
29. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 343:2000;1902-1909.